ABOS
Acumen Pharmaceuticals, Inc. Common Stock
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Best Biotech Stocks 2026 →
Acumen Pharmaceuticals (ABOS) Stock: Buy, Sell, or Hold?
$0.22
-0.01 (-5.22%)
▼
5d:
+1.96%
30d:
-87.51%
90d:
-91.84%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (72%)
Quality Score
52/100
Position
OVERSOLD
30-Day Fair Range
$0.53 – $2.28
Position: OVERSOLD
Forward P/E & Valuation
-0.5x
Next 12M consensus est.
Wall Street Target
$1.00
+358.7% upside
Options IV & Volume
MODERATE Vol
MODERATE volume confirmation
Support / Resistance
$0.19 / $0.35
Trend: Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 MIXED SIGNALS: ABOS shows conflicting indicators. Wait for confirmation before entering.
Get Alerted When ABOS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: ABOS is currently trading at $0.22, which is considered oversold relative to its 30-day fair value range of $0.53 to $2.28.
Technical Outlook: Technically, ABOS is in a downtrend. Immediate support is located at $0.19, while resistance sits at $0.35. Short-term momentum is weak, with the stock down 5.2% recently.
Market Sentiment: The stock scores a mixed 55/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $1.00 (+358.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ABOS is in a downtrend. Immediate support is located at $0.19, while resistance sits at $0.35. Short-term momentum is weak, with the stock down 5.2% recently.
Market Sentiment: The stock scores a mixed 55/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $1.00 (+358.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$0.53 -
$2.28
Company Quality Score
52/100
(HOLD)
Volume Confirmation
MODERATE
Confidence Score
72.1%
Trading Range & Key Levels
30-Day Trading Range
$0.53 -
$2.28
Current vs Trading Range
OVERSOLD
Support Level
$0.19
Resistance Level
$0.35
Current Trend
Downtrend
Technical data as of
Nov 12, 2026
Quantitative Signal Breakdown
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (55/100)
- BEARISH: Downward momentum (-5.2%)
- BULLISH: Trading 358.7% below Wall St target ($1.00)
- WARNING: Composite score 52/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
-0.45
Wall Street Target
$1.00
(+358.7%)
Share ABOS Analysis
Share this live ABOS analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (ABOS)
Bullish
2 Retail Mentions
Reddit / WSB Comments
1
Bullish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 12, 2026
Daily AI digest
AI Retail Discussion Summary:
Trader on StockTwits expresses bullish sentiment towards $ABOS with no recent news articles available.
Key Retail Themes:
Bullish sentiment
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 13, 2026 3:38 AM ET
Data refreshes hourly during market hours. Next update: 4:38 AM
Data refreshes hourly during market hours. Next update: 4:38 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ABOS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
REGN
Regeneron Pharmaceutical… |
BUY
28 analysts |
$978 | 32 SELL |
|
PRAX
Praxis Precision Medicin… |
STRONG BUY
21 analysts |
$650 | 32 SELL |
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
22 analysts |
$296 | 24 SELL |
|
DYN
Dyne Therapeutics Inc |
STRONG BUY
17 analysts |
$34 | 49 HOLD |
|
ACAD
ACADIA Pharmaceuticals I… |
STRONG BUY
20 analysts |
$31 | 48 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive ABOS Research Pages
